Mylan Company Description
Mylan (formerly Mylan Laboratories) knows you may not recognize the names of its drugs, but it hopes you'll appreciate their prices. Through its Mylan Pharmaceuticals subsidiary, the company is the third-largest largest manufacturer of prescription generic drugs in the world (behind Teva and Novartis' Sandoz). The company's pharmaceutical cabinet is full of products including antibiotics, antidepressants, anti-inflammatories, beta-blockers, and laxatives. The company's customers include wholesalers, distributors, retail drugstore chains, and government agencies. The company's Matrix division is the one of the world's largest producers of active pharmaceutical ingredients (API) for generic drugs.
View the Comprehensive Company Description for Mylan
The Company Description provides a historical perspective of Mylan's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Mylan's evolution in the marketplace.
